Fu-Rong Li (Furong Li)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 14

Top Venues

Stem cell research & therapy

Cell death & disease

NPJ genomic medicine

NPJ Regenerative medicine

Shenzhen People's Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Shenzhen People's Hospital

China

Principle Investigator

Publications

Hai-Tao Luo, Qian He, Wei Yang, Fei He, Jun Dong, Chao-Feng Hu, Xiao-Fei Yang, Ning Li, Fu-Rong Li
Single-cell analyses reveal distinct expression patterns and roles of long non-coding RNAs during hESC differentiation into pancreatic progenitors. Stem cell research & therapy 14 (1) (2023)
Hai-Tao Luo, Qian He, Wei Yang, Fei He, Jun Dong, Chao-Feng Hu, Xiao-Fei Yang, Ning Li, Fu-Rong Li
Single-cell analyses reveal distinct expression patterns and roles of long non-coding RNAs during hESC differentiation into pancreatic progenitors. Stem cell research & therapy 14 (1) (2023)
Hai-Tao Luo, Qian He, Wei Yang, Fei He, Jun Dong, Chao-Feng Hu, Xiao-Fei Yang, Ning Li, Fu-Rong Li
Single-cell analyses reveal distinct expression patterns and roles of long non-coding RNAs during hESC differentiation into pancreatic progenitors. Stem cell research & therapy 14 (1) (2023)
Hai-Bo Huang, Hai-Tao Luo, Na-Na Wei, Miao-Ling Liu, Fei He, Wei Yang, Jun Dong, Xiao-Fei Yang, Fu-Rong Li
Integrative analysis reveals a lineage-specific circular RNA landscape for adipo-osteogenesis of human mesenchymal stem cells. Stem cell research & therapy 13 (1) (2022)
Meihua Gong, Fei Yan, Li Yu, Fu-Rong Li
A dopamine-methacrylated hyaluronic acid hydrogel as an effective carrier for stem cells in skin regeneration therapy. Cell death & disease 13 (8) (2022)
Wei Yang, Yong Liang, Yuanyuan Zheng, Hai-Tao Luo, Xiao-Fei Yang, Fu-Rong Li
Identification of Novel Multi-Omics Expression Landscapes and Meta-Analysis of Landscape-Based Competitive Endogenous RNA Networks in ALDH+ Lung Adenocarcinoma Stem Cells. BioMed research international 2022 (2022)
Li-Juan Shao, Qian He, Jingbo Wang, Fei He, Shengcheng Lin, Liujing Wu, Yubiao Gao, Wei Ma, Jun Dong, Xiao-Fei Yang, Fu-Rong Li
MicroRNA-326 attenuates immune escape and prevents metastasis in lung adenocarcinoma by targeting PD-L1 and B7-H3. Cell death discovery 7 (1) (2021)
Hai-Tao Luo, Yuan-Yuan Zheng, Jun Tang, Li-Juan Shao, Yi-Heng Mao, Wei Yang, Xiao-Fei Yang, Yang Li, Rui-Jun Tian, Fu-Rong Li
Dissecting the multi-omics atlas of the exosomes released by human lung adenocarcinoma stem-like cells. NPJ genomic medicine 6 (1) (2021)
Qian He, Zubiao Wu, Wei Yang, Doukou Jiang, Chaofeng Hu, Xiao-Fei Yang, Ning Li, Fu-Rong Li
IFI16 promotes human embryonic stem cell trilineage specification through interaction with p53. NPJ Regenerative medicine 5 (1) (2020)
Ning Li, Doukou Jiang, Qian He, Fei He, Yang Li, Chunyan Deng, Fu-Rong Li
microRNA-181c-5p promotes the formation of insulin-producing cells from human induced pluripotent stem cells by targeting smad7 and TGIF2. Cell death & disease 11 (6) (2020)
Jingbo Wang, Lijuan Shao, Liujing Wu, Wei Ma, Yuanyuan Zheng, Chaofeng Hu, Fu-Rong Li
Expression levels of a gene signature in hiPSC associated with lung adenocarcinoma stem cells and its capability in eliciting specific antitumor immune-response in a humanized mice model. Thoracic cancer 11 (6) (2020)
Xiao-Fei Yang, Shu-Yan Zhou, Ce Wang, Wei Huang, Ning Li, Fei He, Fu-Rong Li
Inhibition of LSD1 promotes the differentiation of human induced pluripotent stem cells into insulin-producing cells. Stem cell research & therapy 11 (1) (2020)
Keda Zhang, Li Yu, Fu-Rong Li, Xue Li, Zhefeng Wang, Xiaoting Zou, Chi Zhang, Kongpeng Lv, Boping Zhou, Samir Mitragotri, Ming Chen
Topical Application of Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells in Combination with Sponge Spicules for Treatment of Photoaging. International journal of nanomedicine 15 (2020)
Jing-Bo Wang, Xue Huang, Fu-Rong Li
Impaired dendritic cell functions in lung cancer: a review of recent advances and future perspectives. Cancer communications (London, England) 39 (1) (2019)

Fu-Rong Li.css-eqlu8i{font-size:small;padding-left:4px;} (Furong Li)

Publication Activity (10 Years)

Top Topics

Top Venues

Fu-Rong Li (Furong Li)